Inflation-Adjusted Medicare Reimbursement for Hip Arthroscopy Fell by 21.1% on Average Between 2011 and 2022
Authors: Kufta AY, Maldonado DR, Go CC, Curley AJ, Padilla P, Domb BG
Journal: Arthroscopy Sports Medicine & Rehabilitation, December 2022
DOI: 10.1016/j.asmr.2022.10.009
Objective
Analyze the change in inflation-adjusted Medicare reimbursement rates for hip arthroscopy over the past decade.
Key Findings
- Medicare reimbursement decreased by 21.1% from 2011 to 2022 (from $1,141.45 to $899.21 on average per procedure).
- The drop may impact surgeons' financial viability and the broader availability of hip arthroscopy.
- Potential downstream effects include access to care and patient costs.
Conclusion
Significant reductions in Medicare reimbursement for hip arthroscopy may influence surgeon practice patterns and patient access.
What Does This Mean for Providers?
- Anticipate potential financial pressures related to declining Medicare reimbursement rates for hip arthroscopy.
- Consider these economic factors when discussing treatment options and planning surgical services.
- Advocate for fair reimbursement policies to maintain patient access and sustainable practice.
